Hmm not sure about that. A co. like Merck certainly makes money at it so it must be profitable. We are a ways away from that prospect though. I think the potential for other applications of cardiocel technology are plenty to generate ample (understatement) with little additional ramp up expense once the systems are in place!
Cardiocel other applications, page-25
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.30 |
Change
0.100(0.76%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.30 | $13.01 | $108.9K | 8.321K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 107 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |